Novartis to Pay $195 Million for Price Fixing
On Monday, it was announced that Novartis AG’s Sandoz subsidiary will pay $195 million in criminal penalties for fixing prices on…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
March 2020
FDA OPDP Working on Two Studies to Better Understand Viewer Comprehension
The United States Food and Drug Administration’s (FDA) Office of Prescription Drug Promotion (OPDP) recently announced that it is…
Sanofi Settles False Claims Act Violation Allegations
On February 28, 2020, the United States Department of Justice (DOJ) announced that Sanofi-Aventis U.S., LLC (Sanofi) agreed to pay…
Biopharmaceutical Industry Addressing Coronavirus
Members of the Pharmaceutical Research and Manufacturers of America (PhRMA) are making strides to address the coronavirus…
FDA Draft Guidance on Combination Products
Recently, the U.S. Food and Drug Administration (FDA) issued draft guidance on requesting feedback from the agency related to…